Tea Monk Fries

Tea Monk Fries is an experienced medical professional currently serving as Executive Director at Novo Nordisk since September 2023. Prior roles at Novo Nordisk include Senior Director for CagriSema and GLP-1 Diabetes, and International Medical Director. Previous experience includes a position as Doctor at Bispebjerg Hospital’s Department of Cardiology, where Tea Monk Fries also completed a PhD focused on the SMARTEX-HF trial. Additional medical practice includes various roles in cardiology and general medicine. Tea Monk Fries holds a Cand.med degree from the University of Copenhagen, completed in 2006.